there are a lot of myths and misconceptions about abraham maslow and self-actualisation � a new paper puts the record straight
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
.
.
march 2016 (31)
.
senator: i�m looking through the trillion-dollar federal budget. i�m looking for the money allocated to fix this horrible situation. where are those funds?
.